Lemercinier X - Search Results

1

Preliminary physical and chemical characterisation of Salmonella typhi VI polysaccharide.

Martinez-Cabrera I, Muñoz Y, Riverón L, Jones C, Lemercinier X, Duarte M, Nápoles L, Muñoz X. Martinez-Cabrera I, et al. Among authors: lemercinier x. Dev Biol (Basel). 2000;103:265-6. Dev Biol (Basel). 2000. PMID: 11214247 No abstract available.

2

Use and validation of an NMR test for the identity and O-acetyl content of the Salmonella typhi Vi capsular polysaccharide vaccine.

Lemercinier X, Martinez-Cabrera I, Jones C. Lemercinier X, et al. Biologicals. 2000 Mar;28(1):17-24. doi: 10.1006/biol.1999.0238. Biologicals. 2000. PMID: 10799051 No abstract available.

3

Physical and chemical parameters for the characterisation of the group C polysaccharide of the Cuban meningococcal BC vaccine.

Martinez-Cabrera I, Muñoz Y, Fajardo EM, Jones C, Lemercinier X, Crane D, Cuevas M, Duarte M, Moreira T, Campa C, Abreu J. Martinez-Cabrera I, et al. Among authors: lemercinier x. Dev Biol (Basel). 2000;103:267-8. Dev Biol (Basel). 2000. PMID: 11214248 No abstract available.

4

Detection of O-acetylated Vi polysaccharide of Salmonella enterica subspecies typhi by enzyme immunoassay.

Rijpkema S, Durrani Z, Lemercinier X, Jones C. Rijpkema S, et al. Among authors: lemercinier x. Biologicals. 2004 Mar;32(1):11-6. doi: 10.1016/j.biologicals.2003.09.002. Biologicals. 2004. PMID: 15026021

5

An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type b.

Lemercinier X, Jones C. Lemercinier X, et al. Biologicals. 2000 Sep;28(3):175-83. doi: 10.1006/biol.2000.0255. Biologicals. 2000. PMID: 10964444

6

Spectroscopic studies of the structure and stability of glycoconjugate vaccines.

Jones C, Lemercinier X, Crane DT, Gee CK, Austin S. Jones C, et al. Among authors: lemercinier x. Dev Biol (Basel). 2000;103:121-36. Dev Biol (Basel). 2000. PMID: 11214231 Review. No abstract available.

7

Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture.

Jones C, Lemercinier X. Jones C, et al. Among authors: lemercinier x. J Pharm Biomed Anal. 2002 Nov 7;30(4):1233-47. doi: 10.1016/s0731-7085(02)00462-4. J Pharm Biomed Anal. 2002. PMID: 12408914

8

Full NMR assignment and revised structure for the capsular polysaccharide from Streptococcus pneumoniae type 15B.

Jones C, Lemercinier X. Jones C, et al. Among authors: lemercinier x. Carbohydr Res. 2005 Feb 28;340(3):403-9. doi: 10.1016/j.carres.2004.12.009. Carbohydr Res. 2005. PMID: 15680595

9

Full assignment of the 1H and 13C spectra and revision of the O-acetylation site of the capsular polysaccharide of Streptococcus pneumoniae Type 33F, a component of the current pneumococcal polysaccharide vaccine.

Lemercinier X, Jones C. Lemercinier X, et al. Carbohydr Res. 2006 Jan 16;341(1):68-74. doi: 10.1016/j.carres.2005.10.014. Epub 2005 Nov 17. Carbohydr Res. 2006. PMID: 16297895

10

Physicochemical studies of the structure and stability of polysaccharide-protein conjugate vaccines.

Jones C, Crane DT, Lemercinier X, Bolgiano B, Yost SE. Jones C, et al. Among authors: lemercinier x. Dev Biol Stand. 1996;87:143-51. Dev Biol Stand. 1996. PMID: 8854011

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters